alk inhibitors for acquired resistance: zykadia and alectinib
Published 8 years ago • 984 plays • Length 3:44Download video MP4
Download video MP3
Similar videos
-
2:00
ceritinib and other second generation alk inhibitors for acquired resistance in alk-positive nsclc
-
4:52
alk tki side effects and acquired resistance - 2022 program: targeted therapies forum
-
2:20
timing of second generation alk inhibitors: first line vs. treatment after acquired resistance
-
9:59
case based panel discussions - alk positive, developing resistance to alk inhibitors and next steps
-
4:14
should a second generation alk inhibitor be first line therapy for patients with alk-positive nsclc?
-
22:46
mechanisms of alk resistance & implications for treatment
-
29:51
current & emerging approaches to acquired resistance for alk/ros1
-
4:58
how do the new alk inhibitor drugs compare to xalkori (crizotinib) for alk lung cancer patients?
-
2:39
grace targeted therapies lung cancer 2021 - return to alectinib -progression on lorlatinib in alk
-
2:15
new alk inhibitor drugs vs xalkori (crizotinib) for alk lung cancer patients
-
26:56
gracecast-085_lung-cancer_alk inhibition: who to screen and options for alk-positive patients
-
1:47
alk rearrangements: what are they, and who has them?
-
23:44
2020 ttf alk session raez sequence of alk inhibitors
-
37:41
gracecast-044_lung-cancer_camidge on alk inhibitors
-
4:44
are there clinically significant differences among the second generation alk inhibitors?
-
5:52
alk positive forum disease progression xalkori
-
6:49
can we improve on xalkori? new agents for patients with an alk-1 rearrangement
-
31:43
new ideas and new treatment options for acquired resistance for alk/ros1
-
10:45
case based panel discussion 2.3 developing resistance to alk inhibitors, areas of progression after